BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25401794)

  • 1. Photoimmunotherapy of gastric cancer peritoneal carcinomatosis in a mouse model.
    Sato K; Choyke PL; Kobayashi H
    PLoS One; 2014; 9(11):e113276. PubMed ID: 25401794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination.
    Nagaya T; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Gastric Cancer; 2019 May; 22(3):463-472. PubMed ID: 30171392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
    Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
    Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer.
    Sato K; Hanaoka H; Watanabe R; Nakajima T; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2015 Jan; 14(1):141-50. PubMed ID: 25416790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer.
    Nagaya T; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Kobayashi H
    Cancer Sci; 2018 Jun; 109(6):1902-1908. PubMed ID: 29676827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
    Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
    Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
    Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
    Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
    Ito K; Mitsunaga M; Arihiro S; Saruta M; Matsuoka M; Kobayashi H; Tajiri H
    BMC Cancer; 2016 Jan; 16():37. PubMed ID: 26810644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near infrared photoimmunotherapy in the treatment of pleural disseminated NSCLC: preclinical experience.
    Sato K; Nagaya T; Choyke PL; Kobayashi H
    Theranostics; 2015; 5(7):698-709. PubMed ID: 25897335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near infrared photoimmunotherapy for lung metastases.
    Sato K; Nagaya T; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Lett; 2015 Aug; 365(1):112-21. PubMed ID: 26021765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
    Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
    Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer.
    Ishida M; Kagawa S; Shimoyama K; Takehara K; Noma K; Tanabe S; Shirakawa Y; Tazawa H; Kobayashi H; Fujiwara T
    Mol Cancer Ther; 2016 Mar; 15(3):402-11. PubMed ID: 26832799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT.
    Nishimura T; Mitsunaga M; Ito K; Kobayashi H; Saruta M
    Gastric Cancer; 2020 Jan; 23(1):82-94. PubMed ID: 31302791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model.
    Sato K; Nagaya T; Nakamura Y; Harada T; Choyke PL; Kobayashi H
    Oncotarget; 2015 Aug; 6(23):19747-58. PubMed ID: 25992770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of light emitting diodes (LEDs) and Lasers in near infrared photoimmunotherapy.
    Sato K; Watanabe R; Hanaoka H; Nakajima T; Choyke PL; Kobayashi H
    Oncotarget; 2016 Mar; 7(12):14324-35. PubMed ID: 26885688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
    Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
    Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green.
    Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H
    Mol Pharm; 2021 Mar; 18(3):1238-1246. PubMed ID: 33502869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.